10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
CVS HEALTH CORP | |||
Ticker: CVS Fiscal Year: 2021 | |||
Consolidated Statements of Operations | |||
Period Ending Dec 31, 2021 10-K (Filed: Feb 9, 2022) | |||
| (In Millions) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | |
| Revenues: | |||
| Premiums | $ 76,132 | 69,364 | 63,122 |
| Net investment income | 1,199 | 798 | 1,011 |
| Total revenues | 292,111 | 268,706 | 256,776 |
| Operating costs: | |||
| Cost of products sold | 175,803 | 163,981 | 158,719 |
| Benefit costs | 64,260 | 55,679 | 52,529 |
| Store impairments | 1,358 | 0 | 231 |
| Goodwill impairment | 431 | 0 | 0 |
| Operating expenses | 37,066 | 35,135 | 33,310 |
| Total operating costs | 278,918 | 254,795 | 244,789 |
| Operating income | 13,193 | 13,911 | 11,987 |
| Interest expense | 2,503 | 2,907 | 3,035 |
| Loss on early extinguishment of debt | 452 | 1,440 | 79 |
| Other income | (182) | (206) | (124) |
| Income before income tax provision | 10,420 | 9,770 | 8,997 |
| Income tax provision | 2,522 | 2,569 | 2,366 |
| Income from continuing operations | 7,898 | 7,201 | 6,631 |
| Loss from discontinued operations, net of tax | 0 | (9) | 0 |
| Net income | 7,898 | 7,192 | 6,631 |
| Net (income) loss attributable to noncontrolling interests | 12 | (13) | 3 |
| Net income attributable to CVS Health | 7,910 | 7,179 | 6,634 |
| Basic earnings per share: | |||
| Income from continuing operations attributable to CVS Health (in dollars per share) | 6.00 | 5.49 | 5.10 |
| Loss from discontinued operations attributable to CVS Health (in dollars per share) | 0.00 | (0.01) | 0.00 |
| Net income attributable to CVS Health (in dollars per share) | 6.00 | 5.48 | 5.10 |
| Weighted average basic shares outstanding (in shares) | 1,319 | 1,309 | 1,301 |
| Diluted earnings per share: | |||
| Income from continuing operations attributable to CVS Health (in dollars per share) | 5.95 | 5.47 | 5.08 |
| Loss from discontinued operations attributable to CVS Health (in dollars per share) | 0.00 | (0.01) | 0.00 |
| Net income attributable to CVS Health (in dollars per share) | 5.95 | 5.46 | 5.08 |
| Weighted average diluted shares outstanding (in shares) | 1,329 | 1,314 | 1,305 |
| Dividends declared per share (in dollars per share) | 2.00 | 2.00 | 2.00 |
| Cost, Product and Service [Extensible List] | http://fasb.org/us-gaap/2021-01-31#ProductMember | http://fasb.org/us-gaap/2021-01-31#ProductMember | http://fasb.org/us-gaap/2021-01-31#ProductMember |
| Product and Service | |||
| Products | |||
| Revenues | 203,738 | 190,688 | 185,236 |
| Services | |||
| Revenues | 11,042 | 7,856 | 7,407 |
| External Links | |
| CVS HEALTH CORP (CVS) Fiscal Year 2021 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |